Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia

NCT05549752 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation Paroxysmal
Coronary Artery Disease Without Residual Ischemia

Interventions

DRUG: Flecainide Injectable Solution
DRUG: Amiodarone Injectable Solution

Sponsor

Hippocration General Hospital

Collaborators

[object Object]
[object Object]